TP53 and cancer: In addition to our discovery that the induction of p53β is specifically required for IR-induction of cellular senescence markers, sporadic reports also suggest that the expression of p53 isoforms is induced in cancer cell lines treated with DNA damage reagents and related to cancer clinical features and outcome [23].